Diamond Hill Capital Management Inc. Has $251.33 Million Holdings in Humana Inc. (NYSE:HUM)

Diamond Hill Capital Management Inc. trimmed its stake in Humana Inc. (NYSE:HUM - Free Report) by 1.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 793,498 shares of the insurance provider's stock after selling 13,070 shares during the quarter. Diamond Hill Capital Management Inc. owned 0.66% of Humana worth $251,333,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also made changes to their positions in the company. Creative Financial Designs Inc. ADV raised its position in Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock valued at $27,000 after acquiring an additional 61 shares in the last quarter. CarsonAllaria Wealth Management Ltd. raised its position in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider's stock valued at $28,000 after acquiring an additional 39 shares in the last quarter. Atwood & Palmer Inc. bought a new position in Humana during the third quarter valued at approximately $29,000. Ashton Thomas Securities LLC bought a new position in Humana during the third quarter valued at approximately $31,000. Finally, Your Advocates Ltd. LLP raised its position in Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock valued at $32,000 after acquiring an additional 45 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Barclays boosted their price objective on shares of Humana from $250.00 to $253.00 and gave the stock an "equal weight" rating in a research note on Thursday, October 31st. TD Cowen boosted their price objective on shares of Humana from $261.00 to $268.00 and gave the stock a "hold" rating in a research note on Monday, November 4th. JPMorgan Chase & Co. boosted their price objective on shares of Humana from $332.00 to $396.00 and gave the stock a "neutral" rating in a research note on Wednesday, August 21st. Sanford C. Bernstein upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $308.00 price objective for the company in a research note on Tuesday, October 8th. Finally, UBS Group dropped their target price on shares of Humana from $380.00 to $250.00 and set a "neutral" rating on the stock in a research report on Friday, October 4th. Twenty investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat, Humana currently has a consensus rating of "Hold" and a consensus price target of $315.86.

Humana Price Performance

Shares of HUM traded down $6.62 during trading hours on Monday, hitting $281.50. The stock had a trading volume of 1,189,301 shares, compared to its average volume of 1,869,083. The company's fifty day moving average is $289.38 and its two-hundred day moving average is $332.82. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $527.18. The stock has a market capitalization of $33.90 billion, a price-to-earnings ratio of 25.52, a P/E/G ratio of 2.28 and a beta of 0.52.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, analysts anticipate that Humana Inc. will post 15.83 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.26%. Humana's dividend payout ratio (DPR) is 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.